E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/3/2012 in the Prospect News PIPE Daily.

MannKind negotiates $75 million public offering of its equity units

Financing conducted with help from Jefferies, Piper Jaffray and Cowen

By Devika Patel

Knoxville, Tenn., Feb. 3 - MannKind Corp. said it priced a $75 million public offering of units with an $11.25 million greenshoe. The deal was announced Jan. 31 and priced Feb. 2.

The company sold 31.25 million units of one common share and a warrant for 0.6 shares at $2.40 per unit. Each whole warrant is exercisable at $2.40 for four years. The strike price and price per unit reflect a 10.45% discount to the Feb. 1 closing share price of $2.68.

Jefferies & Co., Inc., Piper Jaffray & Co. and Cowen and Co., LLC are the joint bookrunning managers. JMP Securities LLC is the co-manager

Settlement is expected Feb. 8.

Proceeds will be used for general corporate purposes, including research and development expenses, capital expenditures, working capital and general administrative expenses.

Valencia, Calif.-based MannKind is a biopharmaceutical company.

Issuer:MannKind Corp.
Issue:Units of one common share and a warrant for 0.6 shares
Amount:$75 million
Greenshoe:$11.25 million
Units:31.25 million
Price:$2.40
Warrants:One warrant for 0.6 shares per unit
Warrant expiration:Four years
Warrant strike price:$2.40
Bookrunners:Jefferies & Co., Inc., Piper Jaffray & Co. and Cowen and Co., LLC
Announcement date:Jan. 31
Pricing date:Feb. 2
Settlement date:Feb. 8
Stock symbol:Nasdaq: MNKD
Stock price:$2.68 at close Feb. 1
Market capitalization:$265.47 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.